Impact of dose and volume on lymphedema

Rays - International Journal of Radiological Sciences

Volumn 30, Issue 2, 2005, Pages 149-155

  Nardone, Luigia ^a   Palazzoni, Giovanni ^a   D'Angelo, Elisa ^a   Deodato, Francesco ^b   Gambacorta, M Antonietta ^a   Miccichè, Francesco ^a   Morganti, Alessio G ^b  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Breast cancer; Lymphedema; Radiotherapy

Indexed keywords

AXILLARY LYMPH NODE; BREAST CANCER; CANCER RADIOTHERAPY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPHEDEMA; MAJOR CLINICAL STUDY; PATHOGENESIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ARM; AXILLA; BREAST NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LYMPHATIC IRRADIATION; LYMPHEDEMA; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 27744494399     PISSN: 03907740     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. RECHT A, EDG SB, SOLIN JL et al for the American Society of Clinical Oncology. Postmastectomy radiotherapy: guidelines of the American Society of Clinical oncology. J Clin Oncol 2001; 19: 1539-1569.
2. PIERCE LJ. Treatment guidelines and technique in delivery of postmastectomy radiotherapy in management of operable breast cancer. J Natl Cancer Inst Monogh 2001; 30: 117-124.
3. TROUNG PT, OLIVOTTO IA, WHELAN TJ, LEVOINE M for the Steering Committee on Clinical Practice Guidelines for the care and treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. CMAJ 2004; 170: 1263-1273.
4. OVERGAARD M, HANSEN PS, OVERGAARD J et al. Post-operative radiotherapy in high risk premenopausal women with breast cancer who receive adjuvant radiotherapy. New Engl J Med 1997; 337: 949-955.
5. RAGAZ J, JACKSON SM, LE N et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. New Engl J Med 1997; 337: 956-962.
6. EBCTCG: Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomized trials. Lancet 2000; 355: 1757-1770.
7. WHELAN TJ, JULIAN J, WRIGHT J, JADAD AR, LEVINE ML. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 2000; 120-129.
8. BENTZEN SM, DISCHE S. Late morbidity: the Damocles Sword of radiotherapy. Radiother Oncol 2001; 61: 219-222.
9. LOBB AW, HARKINS HN. Postmastectomy swelling of the arm with note on effect of segmental resection of the axillary vein at time of radical mastectomy. West J Surg 1949; 57: 550-557.
10. A.L. CHEVILLE, C.L. MCGARVEY, PETREK JA et al. The Grading of Lymphedema in Oncology Clinical Trials. Seminars in Radiation Oncology 2003; 13: 214-225.
11. M. HODKINSON. Lymphoedema: applying physiology to treatment. Eur J Cancer Care 1992; 1: 19.
12. P.S. MORTIMER, C. PADGER, J.G. HALL. Lymphoedema. In: Doyle D, Hanks GWC, MacDonald N eds. Oxford textbook of palliative medicine. Oxford University Press, New York, 1998.
13. MEEK AG. Breast radiotherapy and lymphedema. Cancer 1998; 83 (12 Supplement American): 2788-2797.
14. KISSIN MW, QUERCI DELLA ROVERE G, EASTON D, WESTBURY G. Risk of lymphoedema following the treatment of breast cancer. Br J Surg 1986; 73: 580-584.
15. AITKEN RJ, GAZE MN, RODGER A et al. Arm morbidity within a trial of mastectomy and either nodal sample with selective radiotherapy or axillary clearance. Br J Surg 1989; 76: 568-571.
16. DEWAR JA, SARRAZIN D, BENHAMOU E et al. Management of the axilla in the conservatively treated breast cancer: 592 patients treated at Istitute Gustave-Roussy. Int J Radiat Oncol Biol Phys 1987; 13: 475-481.
17. RECHT A, HOULIHAN MJ. Axillary lymph nodes and breast cancer: A review. Cancer 1995; 76: 1491-1512.
18. DELOUCHE G, BACHELOT F, PREMONT M et al. Conservation treatment of early breast cancer: Long term results and complications. Int J Radiat Oncol Biol Phys 1987; 13: 29-34.
19. LARSON D, WEINSTEIN M, GOLDBERG I et al. Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 1986; 12: 1575-1582.
20. BIJKER N, RUTGERS EJT, PETERSE JL et al. Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy. Cancer 1999; 85: 1773-1781.
21. Powell S, Taghian AG, Coen JJ, et al: Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Int J Rad Oncol Biol Phys 2003; 55: 1209-1215.
22. KWAN W, JACKSON J, WEIR LM et al. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol 2002; 20: 4242-4248.
23. PIERCE LJ, OBERMAN HA et al. Microscopic extracapsular extension in the axilla: is that an indication for axillary radiotherapy? Int J Radiat Oncol Biol Phys 1995; 33: 253-259.
24. ARISTEI C, CHIONNE F, MARSELLA AR et al. Evaluation of level I and II axillary nodes included in the standard breast tangential field and calculation of the administered dose: results of a prospective study. Int J Radiat Oncol Biol Phys 2001; 51: 69-73.
25. SCHLEMBACH PJ, BUCHHOLZ TA, ROSS MI et al. Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation. Int J Radiat Oncol Biol Phys 2001; 51: 671-678.
26. TAKEDA A, SHIGEMATSU N, KONDO M et al. The modified tangential irradiation technique for breast cancer: how to cover the entire axillary region. Int J Radiat Oncol Biol Phys 2000; 46: 815-822.
27. BATES TD. The 10-year results of a prospective trial of post-operative radiotherapy delivered in 3 fractions per week versus 2 fractions per week in breast carcinoma. Br J Radiol 1989; 62: 633-635.
28. BENTZEN SM, DISCHE S. Morbidity related to axillary irradiation in the treatment of breast cancer. Acta Oncol 2000; 39: 337-347.
29. MARCENARO M, SACCO S, PENTIMALLI S et al. Measures of late effects in conservative treatment of breast cancer with standard or hypofractionated radiotherapy. Turaori 2004; 90: 586-591
30. JOHANSSON S, SVENSSON H et al. Dose-response for radiation-induced fibrosis, edema, and neurophaty in breast cancer patients. Int J Radiat Oncol Biol Phys 2002; 52: 1207-1219.
31. DIJKEMA IM, HOFMAN P, RAAIJMAKERS PJ et al. Loco-regional conformal radiotherapy of the breast: delineation of the regional lymph node clinical target volumes in treatment position. Radiother Oncol 2004; 71: 287-295.